Varicella zoster meningitis following COVID-19 vaccination: a report of two cases

Most of the adverse effects reported in patients who have received COVID-19 vaccines have been mild. However, possible serious adverse effects are being monitored cautiously. There have also been a number of case reports of reactivation of varicella zoster infection within 28 days after immunization...

Descripción completa

Detalles Bibliográficos
Autores principales: Buranasakda, Marturod, Kotruchin, Praew, Phanthachai, Kittisap, Mootsikapun, Piroon, Chetchotisakd, Ploenchan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964532/
https://www.ncbi.nlm.nih.gov/pubmed/35367355
http://dx.doi.org/10.1016/j.ijid.2022.03.055
Descripción
Sumario:Most of the adverse effects reported in patients who have received COVID-19 vaccines have been mild. However, possible serious adverse effects are being monitored cautiously. There have also been a number of case reports of reactivation of varicella zoster infection within 28 days after immunization with mRNA COVID-19 vaccines. A few cases have also been reported after viral vector and inactivated COVID-19 vaccination. The incidence of meningitis following varicella zoster virus infection is rare. In the current study, we report two cases of male patients who received two different types of COVID-19 vaccine (inactivated and viral vector) and developed varicella zoster meningitis within 10 days after vaccination.

Ejemplares similares